Suprachoroidal Triamcinolone for Macular Edema in Resistant Non-Infectious Uveitis

This study investigates a new treatment option for people with a specific type of eye inflammation, known as non-infectious uveitis, which leads to swelling in the central part of the retina (called macular edema). The swelling can threaten vision and is particularly challenging to treat in patients who haven't responded to the usual steroid injections around the eye. The study aims to determine if injecting a medicine called triamcinolone directly into a part of the eye called the suprachoroidal space can help reduce the swelling and improve vision. This approach could provide a new treatment possibility for those who haven't found relief with existing methods. Participants in the study will first undergo an assessment that includes a vision test and an eye examination involving a special scan called OCT to evaluate the retina. They will then receive a single injection of triamcinolone into the suprachoroidal space of the eye. This procedure is done with numbing drops in a sterile environment similar to an operating room. The participants will return for follow-up visits one month and three months after the injection to check their vision and retina through repeat tests and scans. They are advised to monitor for any signs of complications, such as pain, redness, or changes in vision, and to contact the clinic if these occur.